Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Circ Genom Precis Med. 2019 May 6;12(6):e002390. doi: 10.1161/CIRCGEN.118.002390

Figure 3.

Figure 3.

CAD-causal regulatory gene networks enriched for ART drug gene signatures. Circular layout of 10 CAD-causal RGNs from the STAGE study22 that were either enriched (yellow), co-expressed (orange) or both (red) with 15 ART drug-induced gene signatures identified in the LINCS database at P<0.05. PI, protease inhibitors; NRTI, nucleoside-analog reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors.